Literature DB >> 19640226

An estimate of the burden of Chagas disease in the United States.

Caryn Bern1, Susan P Montgomery.   

Abstract

Chagas disease causes the highest burden of any parasitic disease in the Western hemisphere. By applying published seroprevalence figures to immigrant populations, we estimate that 300,167 individuals with Trypanosoma cruzi infection live in the United States, with 30,000-45,000 cardiomyopathy cases and 63-315 congenital infections annually. T. cruzi causes a substantial disease burden in the United States.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640226     DOI: 10.1086/605091

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  204 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

Review 2.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation.

Authors:  Richa Dhatwalia; Harkewal Singh; Michelle Oppenheimer; Pablo Sobrado; John J Tanner
Journal:  Biochemistry       Date:  2012-06-05       Impact factor: 3.162

4.  Serological Diagnosis of Chronic Chagas Disease: Is It Time for a Change?

Authors:  Alba Abras; Montserrat Gállego; Teresa Llovet; Silvia Tebar; Mercedes Herrero; Pere Berenguer; Cristina Ballart; Carmen Martí; Carmen Muñoz
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

5.  Dialkylimidazole inhibitors of Trypanosoma cruzi sterol 14α-demethylase as anti-Chagas disease agents.

Authors:  Praveen Kumar Suryadevara; Kishore Kumar Racherla; Srinivas Olepu; Neil R Norcross; Hari Babu Tatipaka; Jennifer A Arif; Joseph D Planer; Galina I Lepesheva; Christophe L M J Verlinde; Frederick S Buckner; Michael H Gelb
Journal:  Bioorg Med Chem Lett       Date:  2013-08-12       Impact factor: 2.823

6.  Chagas Cardiomyopathy in New Orleans and the Southeastern United States.

Authors:  Robert C Hsu; Joshua Burak; Sumit Tiwari; Chayan Chakraborti; Gary E Sander
Journal:  Ochsner J       Date:  2016

Review 7.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

8.  The absence of myocardial calcium-independent phospholipase A2γ results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection.

Authors:  Janhavi Sharma; Christopher S Eickhoff; Daniel F Hoft; David A Ford; Richard W Gross; Jane McHowat
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

Review 9.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

Review 10.  Infectious Diseases of Poverty in Children: A Tale of Two Worlds.

Authors:  Caitlin Hansen; Elijah Paintsil
Journal:  Pediatr Clin North Am       Date:  2016-02       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.